Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Pegylated formulations of rHuTNF-alpha with improved properties prepared in China

July 30, 2001

FLT3 tyrosine kinase inhibitor exerts specific cytotoxicity against certain mutated AML blasts

July 30, 2001

Ilex enters into worldwide license agreement for MUC1 technology

July 30, 2001

Positive opinion from EMEA moves Foscan closer to approval

July 30, 2001

Abbott patents new series of peptide angiogenesis inhibitors

July 27, 2001

CancerVax to seek marketing approval of Canvaxin melanoma vaccine in Canada

July 27, 2001

Thalomid to be submitted for new indication this year

July 27, 2001

Elan licenses European rights to DepoCyte from SkyePharma

July 27, 2001

Antitumor bryostatin analogues synthesized at Leland Stanford

July 26, 2001

Preparation, telomerase-inhibitory and antitumor activity of new series from Aventis

July 26, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 14, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...